Crimson InvasionCrimson Invasion🃏All Altaria cards
Ask about Altaria
Altaria #80 Pokémon card from Crimson Invasion

Altaria 80/111

Crimson Invasion

Find this card on eBay

Affiliate link · we may earn commission

Altaria #80 from Crimson Invasion currently trades at $0.89 raw, with PSA 10 copies reaching $60.00 — a 67.4x grade premium.
Current Prices (USD)
Ungraded
$0.89
PSA 7
$19.99
PSA 8
$19.99
PSA 9
$19.99
PSA 10
$60.00
ACE 10
BGS 10 Black
$390.00
CGC 10 Pristine
$65.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Altaria 80/111 from Crimson Invasion has a current raw market value of $0.89.

Current raw value
$0.89
PSA 9 value
$19.99
PSA 10 value
$60.00
PSA 10 premium vs raw
67.4× raw
View all cards from Crimson Invasion
Collector Intel
67.4x
Raw → PSA 10
High-risk grade
22.5x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 67x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$60
PSA 10 Value
+$34
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$2022.5x raw
PSA 10$6067.4x raw

Frequently asked questions

How much is Altaria #80 from Crimson Invasion worth?+
Altaria #80 from Crimson Invasion is currently worth Raw: $0.89, PSA 9: $19.99, PSA 10: $60.00 based on recent sold listings. Prices update daily from real eBay sales.
Is Altaria #80 worth grading?+
The PSA 10 price of $60.00 is 67.4× the raw price of $0.89. After a ~$25 grading fee, a PSA 10 result would net approximately $59.11 — assuming the card grades a 10.
Where do PokePrices Altaria #80 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.